Skip to content

Inogen Inc

INGN · XNAS

CIK 1294133fmd_041N2A2HBEVJWR6G4JHQ11CKFBManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 57 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Rental revenue––––––––––
Total revenues203249358362308358377316336349
Cost of revenue106128180190170182224189181194
Gross profit97121179172138176154127155154
Research and development5579141722212219
Selling, general and administrative6988134143136151165182176165
Total operating expenses7494141152150167239236197184
Operating income23283820(12)9(85)(109)(43)(30)
Interest expense0–––––––––
Interest and investment income0135103754
Other non-operating income (expense)(0)2347(1)2767
Income before taxes23304024(5)9(83)(102)(36)(23)
Income tax expense29(11)311510(1)(1)
Net income from continuing operations21215221(6)(6)(84)(102)(36)(23)
Net income21215221(6)(6)(84)(102)(36)(23)
Net income to common shareholders21–––––––––
Inogen Inc (INGN) financial statements · FinancialMD